Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Sleep Initiation and Maintenance Disorders 8Anxiety Disorders 6Neoplasms 5Fatigue 4Lymphoma 3Depression 3Breast Neoplasms 3Prostatic Neoplasms 2Nervous System Diseases 2Lymphoma, Follicular 2Glioma 2Weight Loss 1Weight Gain 1Uterine Cervical Neoplasms 1Tobacco Use Disorder 1Substance-Related Disorders 1Sleep Wake Disorders 1Sedentary Behavior 1Ovarian Neoplasms 1Oligodendroglioma 1Neoplasm Metastasis 1Myasthenia Gravis 1Multiple Myeloma 1Mental Disorders 1Meningioma 1Melanoma 1Medication Adherence 1Lung Neoplasms 1Leukemia, Myeloid, Acute 1Hepatitis B 1

Interventions

pembrolizumab 105Specimen Handling 55Magnetic Resonance Spectroscopy 48Biopsy 47Nivolumab 40Paclitaxel 35Gemcitabine 30Radiosurgery 29Carboplatin 28Irinotecan 22Ipilimumab 22Cyclophosphamide 22Cisplatin 22trastuzumab deruxtecan 21Leucovorin 19Capecitabine 19Fluorouracil 18Cetuximab 18Bevacizumab 18130-nm albumin-bound paclitaxel 18Pemetrexed 17Fulvestrant 17Drug Therapy 16Docetaxel 16Taxes 15Oxaliplatin 15olaparib 14abemaciclib 14Radiotherapy 14palbociclib 12

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplasm Metastasis × Cognitive Behavioral Therapy × 1 year × Clear all
NCT06015932 2025-07-29

Group Cognitive Behavior Sessions (CBCSM) to Decrease Distress in Cancer Patients

Mayo Clinic

Phase NA Recruiting
400 enrolled
Tumor-Agnostic

Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡